IDYA
Price
$19.49
Change
+$0.49 (+2.58%)
Updated
Apr 28, 04:44 PM (EDT)
Capitalization
1.66B
15 days until earnings call
RVMD
Price
$41.47
Change
+$2.70 (+6.96%)
Updated
Apr 28, 04:59 PM (EDT)
Capitalization
7.21B
14 days until earnings call
Ad is loading...

IDYA vs RVMD

Header iconIDYA vs RVMD Comparison
Open Charts IDYA vs RVMDBanner chart's image
IDEAYA Biosciences
Price$19.49
Change+$0.49 (+2.58%)
Volume$100
Capitalization1.66B
Revolution Medicines
Price$41.47
Change+$2.70 (+6.96%)
Volume$113.9K
Capitalization7.21B
IDYA vs RVMD Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. RVMD commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Buy and RVMD is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (IDYA: $19.00 vs. RVMD: $38.77)
Brand notoriety: IDYA and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 132% vs. RVMD: 66%
Market capitalization -- IDYA: $1.66B vs. RVMD: $7.21B
IDYA [@Biotechnology] is valued at $1.66B. RVMD’s [@Biotechnology] market capitalization is $7.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, IDYA is a better buy in the long-term than RVMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 5 TA indicator(s) are bullish while RVMD’s TA Score has 5 bullish TA indicator(s).

  • IDYA’s TA Score: 5 bullish, 4 bearish.
  • RVMD’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RVMD is a better buy in the short-term than IDYA.

Price Growth

IDYA (@Biotechnology) experienced а +11.24% price change this week, while RVMD (@Biotechnology) price change was +5.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.03%. For the same industry, the average monthly price growth was +0.98%, and the average quarterly price growth was -8.84%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2025.

RVMD is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+11.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($7.21B) has a higher market cap than IDYA($1.66B). RVMD YTD gains are higher at: -11.363 vs. IDYA (-26.070). IDYA has higher annual earnings (EBITDA): -323.14M vs. RVMD (-677.7M). RVMD has more cash in the bank: 2.29B vs. IDYA (676M). IDYA has less debt than RVMD: IDYA (19.2M) vs RVMD (136M). IDYA has higher revenues than RVMD: IDYA (7M) vs RVMD (0).
IDYARVMDIDYA / RVMD
Capitalization1.66B7.21B23%
EBITDA-323.14M-677.7M48%
Gain YTD-26.070-11.363229%
P/E RatioN/AN/A-
Revenue7M0-
Total Cash676M2.29B30%
Total Debt19.2M136M14%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
61
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYARVMD
RSI
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 7 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
70%
Bearish Trend 7 days ago
83%
Momentum
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 7 days ago
82%
MACD
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 7 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 7 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
80%
Bearish Trend 7 days ago
78%
Advances
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 15 days ago
80%
Declines
ODDS (%)
Bearish Trend 13 days ago
76%
Bearish Trend 13 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
78%
Bullish Trend 7 days ago
87%
Aroon
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 7 days ago
85%
View a ticker or compare two or three
Ad is loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA284.9525.44
+9.80%
Tesla
GME27.460.38
+1.40%
GameStop Corp
SPY550.643.95
+0.72%
SPDR® S&P 500® ETF
AAPL209.280.91
+0.44%
Apple
BTC.X93754.840000-892.085940
-0.94%
Bitcoin cryptocurrency

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with IMNM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-0.37%
IMNM - IDYA
54%
Loosely correlated
-1.41%
RCKT - IDYA
53%
Loosely correlated
-2.69%
NTLA - IDYA
52%
Loosely correlated
+1.59%
ETNB - IDYA
52%
Loosely correlated
+0.58%
XENE - IDYA
52%
Loosely correlated
-1.52%
More

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with ERAS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+0.49%
ERAS - RVMD
53%
Loosely correlated
-0.71%
CRNX - RVMD
52%
Loosely correlated
-2.99%
IDYA - RVMD
51%
Loosely correlated
-0.37%
KYMR - RVMD
51%
Loosely correlated
-0.89%
RCKT - RVMD
51%
Loosely correlated
-2.69%
More